CCT128930
CCT128930 is a potent and selective ATP-competitive Akt2 inhibitor, exhibiting an IC50 of 6 nM and 28-fold selectivity over PKA. This small molecule is a valuable research tool for studying Akt2 signaling in cancer metabolism and proliferation, with applications in both in vitro biochemical assays and cellular pathway analysis.
Product Specifications
CAS Number
885499-61-6
Product Name Alternative
Cell, CCT 128930, CCT128930, CCT-128930, breast cancer, DNA, cycle, damage, Akt, Akt2, Apoptosis, arrest, Autophagy, BT474, p70 S6K, inhibit, Inhibitor, glioblastoma, growth, PKA, PKB, phosphorylation, selective, Protein kinase B, PTEN, S6Kinase, S6 Kinase, U87MG
Field of Research
Cell Biology, Signal Transduction
Purity
99.07% (May vary between batches)
Solubility
Ethanol:6 mg/mL (17.55 mM) ; H2O:<1 mg/mL;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.85 mM) ; DMSO:25 mg/mL (73.13 mM)
Smiles
NC1 (Cc2ccc (Cl) cc2) CCN (CC1) c1ncnc2[nH]ccc12
Molecular Formula
C18H20ClN5
Molecular Weight
341.84
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog